Is Huachansu Beneficial in Treating Advanced Non-Small-Cell Lung Cancer? Evidence from a Meta-Analysis of Its Efficacy Combined with Chemotherapy

Table 3

Result of sensitivity analysis of the studies belonging to different indicator groups.

Indicator	Number of trials	Fixed-effects model			Random-effects model
		RR	95% CI	value	RR	95% CI	value
Objective tumor response	13	1.379	1.190–1.599		1.351	1.168–1.562
One-year survival	4	1.316	1.077–1.607		1.293	1.071–1.561
Performance Status	9	1.397	1.185–1.648		1.351	1.160–1.572
Pain relief	4	1.640	1.293–2.080		1.604	1.273–2.022
Nausea and vomiting	7	0.523	0.333–0.822		0.538	0.297–0.974
Leukocytopenia	9	0.644	0.473–0.876		0.638	0.468–0.871
Thrombocytopenia	5	0.593	0.334–1.054		0.611	0.344–1.083